Bisphosphonates: Risk of Atypical Fractures
Drug Alerts , News / September 21, 2016

FDA is notifying the public of an update to the Warnings and Precautions section of the labels approved to treat osteoporosis, especially bisphosphonates. The update includes the risk of atypical fractures of the thigh – subtrochanteric and ...

Skip to toolbar